The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).
 
Julia K Rotow
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Array BioPharma; Lilly
 
Daniel Botelho Costa
Honoraria - Pfizer; Takeda/Millennium
Consulting or Advisory Role - AstraZeneca; Takeda/Millennium
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck (Inst); Merrimack (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Takeda/Millennium (Inst)
 
Cloud P. Paweletz
Stock and Other Ownership Interests - Xsphera Biosciences
Honoraria - Bio Ascend
Consulting or Advisory Role - DropWorks; Xsphera Biosciences
Patents, Royalties, Other Intellectual Property - Monitoring of cancer by cfDNA
Travel, Accommodations, Expenses - Bio-Rad
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; ARIAD; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Gritstone Bio; Hengrui Therapeutics; Maverick Therapeutics; Merck; Nektar; Neon Therapeutics; Novartis; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Paul Marcoux
No Relationships to Disclose
 
Deepa Rangachari
Consulting or Advisory Role - Advance Medical; DynaMed
Research Funding - Abbvie/Stemcentrx; Bristol-Myers Squibb; Novocure
 
David Allen Barbie
Stock and Other Ownership Interests - Xsphera Biosciences
Consulting or Advisory Role - N-of-One; Qiagen; SAB-Pharma
Research Funding - Bristol-Myers Squibb; Gilead Sciences; Lilly; Novartis
 
Jacob Sands
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; Foundation Medicine; Genentech; Guardant Health; Loxo; Loxo; Medtronic; PharmaMar
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech; Incyte; Incyte
 
Michael L. Cheng
Honoraria - Lynx Group; Potomac Center for Medical Education; WebMD
Consulting or Advisory Role - AstraZeneca; Inivata
Travel, Accommodations, Expenses - Allergan; AstraZeneca; Daiichi Sankyo; Guardant Health; Natera; Potomac Center for Medical Education; Sanofi; WebMD
 
Bruce E. Johnson
Consulting or Advisory Role - Chugai Pharma; Daiichi Sankyo; Foundation Medicine; Hengrui Therapeutics; Lilly; Novartis
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Toshiba (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Geoffrey R. Oxnard
Honoraria - Foundation Medicine; Guardant Health; Sysmex
Consulting or Advisory Role - Abbvie; AstraZeneca; DropWorks; GRAIL; Illumina; Inivata; Janssen; LOXO; Merck; Merck; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)
 
David Michael Jackman
Consulting or Advisory Role - MORE Health
 
David J. Kwiatkowski
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
Kenneth L. Kehl
Consulting or Advisory Role - Aetion
 
Monika D Izdebski
No Relationships to Disclose
 
Christie J. Lau
No Relationships to Disclose
 
Kevin A Vasquez
No Relationships to Disclose
 
Pasi A. Janne
Stock and Other Ownership Interests - Gatekeeper Pharmaceuticals; Loxo
Consulting or Advisory Role - Araxes Pharma; AstraZeneca; Biocartis; Biocartis; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Ignyta; Lilly; LOXO; Merrimack; Mirati Therapeutics; Novartis; Pfizer; Roche/Genentech; Sanofi; SFJ Pharmaceuticals Group; Takeda; Voronoi Health Analytics
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Puma Biotechnology; Revolution Medicines; Takeda
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a DFCI owned patent on EGFR mutations licensed to Lab Corp. I receive post-marketing royalties from this invention